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The establishment of the epigenetic mark H4K20me1 (monomethylation of H4K20) by PR-Set7 during G2/M
directly impacts S-phase progression and genome stability. However, the mechanisms involved in the regulation of
this event are not well understood. Here we show that SirT2 regulates H4K20me1 deposition through the
deacetylation of H4K16Ac (acetylation of H4K16) and determines the levels of H4K20me2/3 throughout the cell
cycle. SirT2 binds and deacetylates PR-Set7 at K90, modulating its chromatin localization. Consistently, SirT2
depletion significantly reduces PR-Set7 chromatin levels, alters the size and number of PR-Set7 foci, and decreases
the overall mitotic deposition of H4K20me1. Upon stress, the interaction between SirT2 and PR-Set7 increases
along with the H4K20me1 levels, suggesting a novel mitotic checkpoint mechanism. SirT2 loss in mice induces
significant defects associated with defective H4K20me1–3 levels. Accordingly, SirT2-deficient animals exhibit
genomic instability and chromosomal aberrations and are prone to tumorigenesis. Our studies suggest that the
dynamic cross-talk between the environment and the genome during mitosis determines the fate of the
subsequent cell cycle.
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The members of the Sir2 family of NAD+-dependent
deacetylases, also known as Sirtuins, are crucial factors
in the response to metabolic, oxidative, or genotoxic stress
(Chalkiadaki and Guarente 2012). The capacity of Sirtuins
to sense these compromising conditions appears to be due
to the requirement of NAD+ for their enzymatic activity
(Imai et al. 2000; Landry et al. 2000; Smith et al. 2000). A
second enzymatic activity, amono-ADP ribosyltransferase
activity, has been reported for some Sirtuins, although the
relevance of this activity for the Sir2 family remains
a matter of debate (Tanny et al. 1999). Sirtuins participate
in a myriad of functions directed at facilitating adapta-
tion to these stress conditions at both the cellular and
organismal levels. These functions include metabolic
homeostasis, survival under stress, the maintenance of
genomic stability, and cell differentiation and development
(Saunders and Verdin 2007; Finkel et al. 2009).
Sirtuins have been present since early in evolution.
From this time, they have apparently played a major role
in the cross-talk between environmental stimuli and geno-
mic information (Vaquero 2009). In fact, eukaryotic Sirtuins
often exert their functions by affecting chromatin. These
functions include gene silencing, chromatin structure
modulation, DNA damage signaling, DNA repair, and cell
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cycle regulation. The mechanisms through which Sirtuins
act on chromatin involve the deacetylation of both histone
and nonhistone proteins ranging from chromatin machin-
ery enzymes to transcription factors.
SirT2 is among the least understood of the seven
mammalian Sirtuins. To date, it has been linked to the
regulation of mitotic progression (Dryden et al. 2003),
oxidative stress response (Wang et al. 2007), metabolism
(Jiang et al. 2011), microtubule dynamics (North et al.
2003), cell migration (Pandithage et al. 2008), apoptosis
(Li et al. 2011), neurotoxicity (Outeiro et al. 2007), and the
inhibition of differentiation (Jing et al. 2007; Li et al.
2007). The role of SirT2 in cell cycle regulation is par-
ticularly intriguing. SirT2 has been found to be up-regulated
during mitosis, and its overexpression has been reported
to induce the lengthening of mitosis (Dryden et al. 2003)
and shortening of G1 (Bae et al. 2004). Additionally, micro-
injection of either SirT2 or its yeast ortholog, Hst2p, has
been shown to inhibit starfish oocyte maturation and
embryonic cell division (Borra et al. 2002). Primarymouse
embryonic fibroblasts (MEFs) derived from SirT2 knock-
out mice show a very limited decrease in the length of
mitosis but longer G1 and shorter S phases—a finding that
confirms that SirT2 has a significant role in the cell cycle
and, at least in part, a direct impact on G1/S (Vaquero
et al. 2006). Recent studies have suggested a role for SirT2
in the control of mitotic exit by acting on the anaphase-
promoting complex; namely, via the deacetylation of its
coactivators, APCCDH1 and CDC20 (Kim et al. 2011).
A very interesting link between chromatin regulation
and SirT2 that directly points to cell cycle regulation is
the acetylation of Lys 16 on histone H4 (H4K16Ac), a
mark that has been proposed to directly regulate chro-
matin structure (Shia et al. 2006). Previous studies have
determined that in terms of deacetylase activity, SirT2
is highly specific for H4K16Ac (Vaquero et al. 2006), in
contrast to the other major mammalian H4K16Ac de-
acetylase, the Sirtuin SirT1, which has a wider specificity
(Vaquero et al. 2004). Studies have shown that H4K16Ac
inhibits the folding of chromatin fiber in vitro and there-
fore facilitates the formation of higher orders of chromatin
organization (Shogren-Knaak et al. 2006; Robinson et al.
2008). The acetylation/deacetylation of H4K16 has been
implicated in transcriptional regulation (Dou et al. 2005;
Bell et al. 2007), DNA repair (Jazayeri et al. 2004) and re-
combination (Cesarini et al. 2012), many epigenetic phe-
nomena (Vaquero et al. 2007), aging (Dang et al. 2009), and
cancer (Fraga et al. 2005). These findings consistently
support an important role for the acetylation/deacetylation
of H4K16 in chromatin dynamics. Furthermore, H4K16Ac
is tightly regulated during the cell cycle: Its levels peak
during S phase and drop dramatically in the G2/M transi-
tion. SirT2 is present in the cytoplasm throughout the cell
cycle, except during the G2/M transition, when it is trans-
ported to the nucleus (Wilson et al. 2006; North and Verdin
2007a), where it globally deacetylates H4K16Ac before
mitosis begins. MEFs derived from SIRT2/ mice show
hyperacetylation of H4K16Ac duringmitosis, in contrast to
those from SIRT1/ mice, which have apparently normal
H4K16Ac levels (Vaquero et al. 2006). Interestingly, the
effects of SirT2 on chromatin appear to be restricted to
early mitosis, as SirT2 dissociates from the chromosomes
during metaphase (Vaquero et al. 2006).
Several levels of interplay have been identified between
H4K16Ac and other histonemarks. The best characterized
of these are linked to the transcriptional role of H4K16Ac
at the level of initiation (H3K4me3 and H3S10P) or elonga-
tion (H3K36me3) (Dou et al. 2005; Bell et al. 2007; Zippo
et al. 2009). Interestingly, an antagonism betweenH4K16Ac
and H4K20 methylation has been proposed. In vitro stud-
ies with peptides have shown that H4K16Ac could in-
hibit the monomethylation of H4K20 (H4K20me1) by the
histone methyltransferase (HMT) PR-Set7 (also known as
SET8 or KMT5A) (Nishioka et al. 2002a). The relevance of
this antagonism lies in the importance of H4K20 mono-,
di-, or trimethylation in the control of cell cycle progres-
sion, chromosome compaction, development, DNA re-
pair signaling, and genome stability (Sanders et al. 2004;
Schotta et al. 2004, 2008; Karachentsev et al. 2005; Oda
et al. 2009). H4K20me1 is established in late G2/early M
by PR-Set7 and is paramount in metaphasic chromosome
compaction and mitotic exit during mitosis (Houston
et al. 2008; Oda et al. 2009) and in DNA repair and DNA
replication (Jorgensen et al. 2007; Tardat et al. 2007,
2010). During lateM/early G1, some H4K20me1 is further
methylated into H4K20me2 (required for DNA repair) or
H4K20me3 (required for heterochromatin structure for-
mation) by the HMTs Suv4-20h1 or Suv4-20h2, respec-
tively (Sanders et al. 2004; Schotta et al. 2004, 2008). PR-
Set7 levels are tightly regulated during the cell cycle, and
this protein is clearly detected from lateM to earlyG1 (Oda
et al. 2009). Despite the importance of H4K20methylation
to cell cycle progression, little is known about the signals
and pathways that regulate this modification or the mech-
anisms through which the enzymes involved are modu-
lated. The only clue currently is the reported phosphor-
ylation of S29 in PR-Set7 by CDK1, which appears to be
important for regulating the binding of PR-Set7 to chro-
matin and for preventing its degradation by APCCDH1-
mediated polyubiquitination (Wu et al. 2010).
While investigating the role of SirT2 and H4K16Ac in
cell cycle control and genome stability, we discovered roles
for SirT2 in establishing PR-Set7-mediated H4K20me1
during early mitosis and in the maintenance of genome
stability. We deciphered an unexpected and close func-
tional relationship between these two enzymes and linked,
for the first time, the deposition of H4K20 methylation to
a mitotic checkpoint and to the SirT2-dependent stress
response. Here we describe an unprecedented functional
explanation for the maintenance of genomic stability by
Sirtuins and provide strong evidence that supports a dy-
namic role of Sirtuins in controlling the cell cycle through
the modulation of epigenetic regulatory information.
Results
Tissue from SirT2-deficient mice shows H4K16
hyperacetylation
To understand the functional relationship among SirT2,
H4K16Ac, and mitosis, we aimed to determine the
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consequences of SirT2 loss in vivo. SirT2 knockout mice
were generated by replacing exons 5 and 6 and part of
exon 7 of the SIRT2 gene (Fig. 1A–D) with a Neo gene
(Materials and Methods). The resultant mice exhibited
a complete lack of the SirT2 protein (Fig. 1C). These mice
did not show any obvious developmental defect and
postnatally appeared to be normal. In agreement with
previous findings involving the SIRT2/MEFs (Vaquero
et al. 2006), the SIRT2/ mice showed hyperacetylation
of H4K16Ac in different tissues, such as the kidney
(Fig. 1E) and liver (Supplemental Fig. 1). Moreover, no
significant changes in the levels of another histone H4
mark, H4K12Ac, were observed (Fig. 1E). In agreement
with our previous results in primary MEFs, proliferating
cells in these tissues showed H4K16 hyperacetylation
during mitosis (marked by H3S28P) compared with cells
in wild-type tissues (Fig. 1F).
SirT2 alters H4K20me1 deposition during early mitosis
Once we confirmed the functional link between H4K16Ac
and SirT2 in vivo, we aimed to determine the role of this
global deacetylation during the cell cycle. We envisaged
two different scenarios as the most likely mechanisms.
First, considering the proposed role of H4K16Ac in in-
hibiting chromatin compaction, H4K16Ac hypoacetyla-
tion might be required for the proper compaction of
metaphase chromosomes. However, as we explain below,
the current body of evidence does not completely support
this explanation. Second, H4K16Ac deacetylation ap-
pears to be a prerequisite for certain processes during
mitosis. Considering the proposed interplay between K16
and K20 in the histone H4 tail (Fig. 2A; Nishioka et al.
2002b), we hypothesized that SirT2 could be involved
in H4K20 methylation. Interestingly, during mitosis,
H4K20me1 is chiefly established between the G2/M
transition and metaphase, which is the same time that
SirT2 localizes to the chromatin and deacetylates H4K16Ac
(Vaquero et al. 2006). To test this hypothesis, we analyzed
the levels of H4K16Ac and H4K20me1 in metaphasic
chromosomes in cells derived from either wild-type or
SIRT2/ mice. Interestingly, the SIRT2/ metaphasic
chromosomes exhibited H4K16 hyperacetylation and an
associated loss of H4K20me1 (Fig. 2B,C), thereby con-
firming that the antagonism is real—at least during early
mitosis. Other findings support a functional link between
SirT2 and the establishment of H4K20me1. First, the
SIRT2/ mouse kidney exhibited significantly lower
levels of H4K20me1 compared with wild type but did
not show any change in the levels of H3K4me3 (Fig. 2D).
Second, an analysis of the changes in the H4K20me1
distribution in SIRT2/ and wild-type primary fibro-
blasts revealed that the loss of H4K20me1 caused by
SirT2 loss occurred chiefly during mitosis and did not
affect other cell cycle phases (Fig. 2E). Interestingly, this
effect was SirT2-specific, as indicated by the absence of
Figure 1. SIRT2/mice show H4K16 hyperacetylation in vivo. (A) Schematic of the generation of SIRT2/mice. Integration of a neo
cassette led to deletion of exons 5 and 6 and part of 7. (B) Genotyping of wild-type (WT), SIRT2+/, and SIRT2/ mice. Genomic DNA
was extracted from ear punches, as described. (C) SirT2 protein levels measured by Western blot in wild-type or SIRT2/ MEFs (D)
Young SIRT2/ adults do not show any characteristic phenotype. (E) H4K16Ac and H4K12Ac levels in kidney cryosections derived
from wild-type or SIRT2/ mice, as detected by immunohistochemistry. (F) H4K16Ac levels in kidney mitotic cells, identified by
staining with the marker H3S28P, as detected by immunohistochemistry of cryosections.
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any clear defect in the H4K20me1 levels during mitosis
(Fig. 2F) in SIRT1/ MEFs (Vaquero et al. 2004). This
effect was directly dependent on SirT2 activity because
the expression of exogenous active SirT2 but not a SirT2
catalytically inactive point mutant rescued the levels of
H4K20me1 (Fig. 2G). Considering the relatively low pro-
liferation rate of kidney cells, the global H4K20me1
hypomethylation shown in Figure 2D may indicate that
this effect is also important for quiescence. Overall, the
aforementioned data establish a specific role for SirT2 in
the deposition of H4K20me1 during mitosis.
SirT2 interacts with PR-Set7 and modulates its
activity, chromatin localization, and distribution
during early mitosis
This functional link suggests that SirT2 might modulate
the function of PR-Set7. The most obvious explanation is
that SirT2 is required for the deacetylation of H4K16Ac,
which in turn enables H4K20me1 deposition by the
HMT. Previous studies have shown that in contrast to
the strict nucleosomal specificity of wild-type PR-Set7,
the HMTactivity of a PR-Set7 deletion mutant capable of
targeting H4 peptides is inhibited by the presence of K16
acetylation in these peptides (Nishioka et al. 2002b).
However, whether this inhibitory effect holds in the con-
text of the wild-type enzyme and nucleosomes has not
yet been reported. Thus, to answer this question, we per-
formed a PR-Set7 HMT assay using substrates that were
recombinant nucleosomes containing an H4 N-terminal
tail generated by chemical ligation to contain either un-
modified or acetylated K16. A titration of nucleosomes in
these HMT assays clearly demonstrated that the inter-
play between H4K16Ac and PR-Set7 in the context of
nucleosomes does indeed hold (Fig. 3A,B). This inhibitory
effect of H4K16Ac was not due to an alteration produced
by the chemical ligation, since the H4K16Ac-containing
recombinant octamers (rOcts) did not inhibit the activity
of a bacterially expressed catalytic SET domain of the
H3K9me2-specific HMT G9a (Fig. 3A). Preincubation of
SirT2 with native nucleosomes and NAD+ significantly
increased the specific HMT activity of PR-Set7 (Fig. 3C,
lane 4), a finding that supports a positive effect of SirT2 on
PR-Set7, at least partially, through H4K16Ac deacetylation.
Furthermore, part of this effect by SirT2 on PR-Set7 in
Figure 2. SirT2 regulates H4K20me1 deposition in early mitosis. (A) Interplay between H4K16 and H4K20 in the N-terminal tail of
histone H4. (B) IF of metaphase cells from wild-type (WT) or SIRT2/ MEFs. Cells were stained with antibodies against H3S28P,
H4K20me1, and H4K16Ac and then counterstained with DAPI. (C) Quantification of multiple experiments as in B measuring
H4K20me1 levels versus H4K16Ac. (D) H4K20me1 and H3K4me3 levels in kidney cryosections prepared from wild-type or
SIRT2/ mice. (E) Quantification of the mean intensity of H4K20me1 in IF assays from wild-type or SIRT2/ MEFs through the
different stages of the cell cycle (n > 20 for each time point). (F) Quantification of mean intensity of H4K20me1 in metaphasic
chromosomes of wild-type or SIRT1/MEFs (n > 20 for each time point). (G) Quantification of the levels of H4K20me1 in SIRT2/
MEFs upon overexpression of SirT2 wild type or catalytically inactive point mutant H150Y.
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Figure 3. SirT2 regulates H4K20me1 deposition by directly interacting with PR-Set7. (A, top) HMT assay of recombinant PR-Set7
using as substrates increasing amounts (0.125, 0.25, 0.5, and 1 mg) of recombinant nucleosomes either unmodified (wild-type [WT]) or
containing symmetrical H4K16Ac assembled by chemical ligation. (Bottom) As a control, 0.125, 0.25, 0.5, and 1 mg of recombinant
octamers (rOct) (either wild type or acetylated in the H4K16A by chemical ligation) were tested in HMT assays as substrates of the
recombinant catalytic SET domain of G9a. These octamers were previously used to reconstitute the recombinant nucleosomes used at
top. In both HMTassays, histone proteins were stained with Coomassie blue (CBB). A representative experiment of a set of three assays
is shown in each case. (B) Quantification of similar experiments shown in the top part of A but using 200 ng instead of 50 ng of
recombinant PR-Set7 was quantified by scintillation counting. Data shown are means and SEM of two experiments. (C) HMT assay of
PR-Set7 using oligonucleosomes purified from HeLa cells as substrates preincubated with or without SirT2 6 NAD+. Histone proteins
were stained with Coomassie blue (CBB). (D) Colloidal-stained gel of Myc-PR-Set7 purified with Myc resin from nuclear extract (NE)
and chromatin pellet (CP) of Myc-PR-Set7-overexpressing cells. The band corresponding to PR-Set7 was cut and analyzed by mass
spectrometry (see the Supplemental Material). Endogenous SirT2 peptide sequences identified only in chromatin pellet are shown in
blue. (E) Myc resin immunoprecipitation of extracts from HeLa cells previously transfected with Flag-SirT2 and/or PR-Set7-myc as
indicated. (I) Input; (FT) flow-through; (E) elutions. (F) PR-Set7 foci in wild-type and SIRT2/ fibroblasts detected by IF experiments in
G2/M cells (bar, 5 mm) as described previously (Tardat et al. 2010). (G) Quantification of the mean volume of PR-Set7 foci from cells at
different stages of the cell cycle (n > 20 for each time point). (H) The number of foci in the same experiment was quantified (data shown).
(I) Levels of endogenous PR-Set7 in insoluble chromatin fractions of wild-type or SIRT2/ MEFs either asynchronous or blocked in
mitosis with colcemid. Histone H4 Western blot is shown as a loading control. (J) Primary structure of PR-Set7. The sequence of one of
the detected K90-acetylated peptides is indicated in yellow. The catalytic SET domain is shown in green. (K, rows 1,2) Mass
spectrometry analysis of PR-Set7 purified from cells in different conditions found an acetylation site in K90 of PR-Set7 (indicated in the
PR-Set7 sequence shown above) in cells previously treated with HDAC inhibitors N+TSA but not in untreated cells. Analysis of
tandem mass spectrometry parameters in K90 identification indicates a high confidence in the detection. The table includes three
parameters: andromeda score (peptide score), localization probability, and PEP (posterior error probability of the identification). (Rows
3,4) Purified PR-Set7 (N+TSA) was incubated with SirT2 6 NAD+. (L,M) Quantification of the number of foci per cell (L) and the mean
intensity of PR-Set7 per foci and per nucleus (M) of an experiment similar to that in F but using primary MEFs overexpressing PR-Set7
wild-type or mutant proteins, as indicated. (N) Western blot from whole-cell extract (Total) or chromatin pellet (Chr) prepared from
HeLa cells previously transfected with an increased amount of expression vector encoding either Flag-tagged PR-Set7 wild type or
K90Q. Tubulin was used as a control of whole-cell extract, and histone H4 was used as control of chromatin pellet.
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vitro was independent of the catalytic activity of SirT2
(Fig. 3C, lane 3). The observation that SirT2 also in-
creased the PR-Set7-specific activity in the absence of
NAD+ suggests that the two factors may interact stably.
This possibility was supported by the mass spectrometry
analysis of elutions from Myc-tagged PR-Set7 affinity
purification using Myc resin, in which we unequivocally
identified endogenous SirT2 as one of the proteins pulled
down by PR-Set7 in the chromatin-insoluble fractions
(Fig. 3D). Interestingly, no SirT2 was identified in the PR-
Set7 pull-downs from the soluble nuclear extracts (Fig. 3D)
or in any other PR-Set7-unrelated Myc immunoprecipita-
tion of the chromatin pellet (data not shown). Further
studies clearly demonstrated that PR-Set7 immunopre-
cipitates SirT2 in HeLa cells (Fig. 3E), and pull-down
studies with recombinant proteins confirmed that the
two proteins interact directly (Supplemental Fig. 2A). This
interaction was drastically reduced with a catalytically
inactive SirT2 point mutant, supporting a role for SirT2
activity in these processes (Supplemental Fig. 2B). Inter-
estingly, PR-Set7 immunoprecipitated only the upper band
of SirT2 (Fig. 3E, lane 3), which corresponds to its phos-
phorylated form (SirT2 is phosphorylated chiefly during
mitosis) (Supplemental Fig. 2C; North and Verdin 2007b).
Thus, our studies show that SirT2 promotes the enzy-
matic activity of PR-Set7 through the deacetylation of
H4K16Ac and through the direct binding of both factors,
which most likely involves a conformational change in
PR-Set7.
The interplay between SirT2 and PR-Set7 during mito-
sis apparently includes other levels of regulation, as re-
flected by the observation that PR-Set7 mitotic foci were
dramatically altered in SirT2-deficient cells. The loss of
SirT2 induced a higher number of foci, but these were
significantly smaller than those in the wild-type cells (Fig.
3F–H). Moreover, SIRT2/ cells also exhibited signifi-
cantly decreased levels of PR-Set7 associated with in-
soluble chromatin, particularly during mitosis (Fig. 3I),
whereas the total amount of PR-Set7 was unaffected (Sup-
plemental Fig. 2D). The findings that the activity and
localization of PR-Set7 as well as the architecture of its
foci were all affected in the absence of SirT2 strongly
suggest that SirT2 activity is also required for the proper
loading of the PR-Set7 enzyme.
SirT2-mediated PR-Set7 K90 deacetylation regulates
its chromatin localization
We also tested the possibility that SirT2 modulates PR-
Set7 function via the direct deacetylation of PR-Set7. Our
mass spectrometry experiments identified a single resi-
due acetylated in PR-Set7 at K90 (Fig. 3J,K; data not shown).
SirT2 can specifically deacetylate this residue given that
no K90Ac was detected after the incubation of PR-Set7
with SirT2 plus NAD+ (Fig. 3K). However, the acetylation/
deacetylation of K90 did not appear to have a significant
effect on the enzymatic activity of PR-Set7. Thus, PR-Set7
purified from cells previously incubated with the his-
tone deacetylase (HDAC) inhibitors nicotinamide and
TSA (N+TSA) did not result in any difference in the
HMT activity (Supplemental Fig. 2E). Moreover, incu-
bation of this ‘‘hyperacetylated’’ PR-Set7 with SirT2 and
NAD+ did not produce any change in the PR-Set7 HMT
activity (Supplemental Fig. 2E). A very important clue in
determining the role of this modification came from the
comparative analysis of PR-Set7 wild type with K90
point mutations to arginine (K90R; to mimic deacetylated
lysine) or to glutamine (K90Q; to mimic acetylated
lysine). All three forms showed similar HMT-specific
activities (Supplemental Fig. 2F; data not shown). In-
terestingly, the immunofluorescence (IF) analysis of the
nuclear levels of the PR-Set7 wild-type, K90R, and K90Q
proteins and the features of the foci formed by each
protein after overexpression in primary MEFs revealed
that the number of K90Q foci per cell was nearly double
that formed by the wild-type form, whereas K90R formed
significantly fewer foci under the same conditions (Fig.
3L). Moreover, although the intensity level of K90Q in
each focus was, on average, lower than that of K90R or
wild type (see PR-Set7 mean foci intensity) (Fig. 3M), the
total amount of K90Q retained in the foci, and therefore
in the chromatin pellet, was significantly higher than
that in the wild-type or K90R-overexpressing cells (Fig.
3M). In support of these results, a Western blot of the
chromatin pellet from cells under the same conditions
clearly showed significantly higher levels of K90Q than
wild type in these fractions (Fig. 3N).
Interestingly, pull-down experiments between purified
SirT2 and wild-type, K90R, or K90Q PR-Set7 showed that
SirT2 binds with a stronger affinity to K90R than to wild
type or K90Q (Supplemental Fig. 2G,H). PR-Set7 over-
expression in HeLa cells led to a greater incorporation of
endogenous or exogenous SirT2 in insoluble chromatin
during mitosis, but SirT2 overexpression did not have the
same effect on endogenous or exogenous PR-Set7 levels
(Fig. 4A; Supplemental Fig. 3A,B). These results suggest
that PR-Set7 may first recruit SirT2 to the chromatin and
that SirT2 may in turn help stabilize PR-Set7 on the chro-
matin by deacetylating K90. Altogether, these results sup-
port a role for K90 in the regulation of PR-Set7-chromatin
dynamics.
SirT2 and PR-Set7 may participate in a mitotic
checkpoint mechanism
We then tackled another open question: Considering the
role of SirT2 in the response to oxidative and genotoxic
stress (Wang et al. 2007), is the functional link between
SirT2 and PR-Set7 related to stress response? We found
strong evidence to suggest that this is the case. First,
oxidative stress increased the levels of both PR-Set7 and
SirT2 in insoluble chromatin (Fig. 4A). Second, oxidative
stress generated by H2O2 induced a significantly stronger
interaction between SirT2 and PR-Set7 (Fig. 4B), even
though the stress led to a decrease in the PR-Set7 levels in
the whole cell, as was previously reported (Supplemental
Fig. 3C; Oda et al. 2010). Third, although wild-type
primary fibroblasts exhibited up-regulation of H4K20me1
under conditions of stress compared with control condi-
tions, this up-regulationwas abrogated in SIRT2/ fibroblasts
Serrano et al.
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Figure 4. SirT2 and PR-Set7 may participate in a mitotic checkpoint. (A) Experiment similar to that in Figure 3I, but in this case,
determining the levels of exogenous SirT2-HA and Flag-PR-Set7 in insoluble chromatin fractions after overexpression of the indicated
vectors in HeLa cells. (Lanes 3,6,9) The G2/M-blocked cells were also subjected to H2O2-induced oxidative stress. Whole-cell levels of
SirT2-HA and Flag-PR-Set7 are shown in Supplemental Figure 3A. (B) Immunoprecipitation with Flag resin of extracts from HeLa cells
previously transfected with Flag-SirT2 and/or PR-Set7-myc under normal conditions or H2O2-induced oxidative stress. (C) H4K20me1
levels in IF experiments from wild-type (WT) and SIRT2/ primary fibroblasts at different stages of the cell cycle, cultured under
normal conditions or under oxidative stress. The values shown represent the ratio of H4K20me1 levels in treated cells (100 mM H2O2
for 1 h) to those of untreated cells. (*) The differences between wild-type and SIRT2/ cells in S phase and G2/M were significant (P <
0.01). (D) The cells sorted at G2/M were incubated with 100 mMH2O2 for 1 h. Cells were harvested either immediately after 1 h of H2O2
treatment (t0) or at 15 h post-treatment (t15), fixed, and then analyzed by FACs. DNA was stained with 7AAD. (E) FACS analysis of
mitotic cells shown inD. Wild-type and SIRT2/MEFs treated or untreated for 1 h with 100 mMH2O2 sorted by DNA content (7AAD)
and a mitotic cell marker (H3 phosphorylation). (F) Quantification of the percentage of mitotic cells in wild-type and SIRT2/ MEFs
shown in E.
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(Fig. 4C). Finally, sorted wild-type cells in G2/M that were
treated with H2O2 remained blocked in G2/M 15 h post-
treatment. In contrast, SirT2-deficient cells were not
blocked: They progressed through G1, where the induced
damage resulted in higher levels of apoptosis (Fig. 4D). In
a similar experiment focused exclusively on cells un-
dergoing mitosis, oxidative stress treatment led to a sig-
nificantly greater population increase of mitotic SIRT2/
cells compared with wild-type cells (Fig. 4E,F). Interest-
ingly, this response was conserved under other types of
stress (data not shown). Consistent with a direct role of
SirT2 in this response to stress, expression of ectopic SirT2
under the same conditions as in Figure 4D rescued cells
from theG2/Mblock (Supplemental Fig. 3D,E). Altogether,
these findings suggest that PR-Set7, SirT2, and H4K20me1
participate together in the mitotic stress response.
SirT2 knockout cells exhibit drastically altered levels
of H4K20me2/3 during the cell cycle and show various
defects previously associated with a decrease in both
marks
The chromatin mark H4K20me1 is not only paramount
for cell cycle progression, but also required for the di- and
trimethylation of H4K20 by Suv4-20 enzymes in late
M/early G1 (Schotta et al. 2004). Interestingly, the de-
crease in H4K20me1 that occurs in SIRT2/ MEFs cor-
relates to significantly lower levels of H4K20me2 and
H4K20me3 (Fig. 5A–C), which corroborates a role for SirT2
in the regulation of H4K20me1 deposition. Furthermore,
and in contrast toH4K20me1, the levels of H4K20me2 and
H4K20me3 were also lower in all phases of the cell cycle
(Fig. 5B,C). Moreover, the observations that the loss of
Figure 5. SIRT2/ cells suffer from drastically low levels of H4K20me2,3 and share common defects with Su(var)4-20 double knockouts. (A)
Levels of H4K20me2 and H4K20me3 in wild-type (WT) or SIRT2/MEFs determined by IF. S-phase cells were visualized by EdU staining. (B)
Quantification of experiment inA through the different stages of the cell cycle. (C) Quantification (as percentage) of the decrease in H4K20me1,
H4K20me2, and H4K20me3 levels in SIRT2/ and wild-type cells at the different stages of the cell cycle. The data shown were generated in
the experiment corresponding to B and Figure 2E. (D) Cell cycle profiles of wild-type and SIRT2/ fibroblasts obtained by FACS analysis using
DNA content either alone (left panel) or in combination with EdU (right panel). The values shown are the percentage of polyploid cells (DNA
content >4N). (Right panels) EdU staining denotes the presence of polyploid cells with rereplicated DNA. (E) Overlay histograms showing
expression of Cyclin B1 in polyploid cells from wild-type and SIRT2/ fibroblasts. (F) Analysis of S-phase entrance of wild-type and SIRT2/
fibroblasts. Cells were sorted at G1 and harvested at the indicated times. S-phase progression was measured by FACS as inD. (G) mRNA levels
of pericentromeric g-satellite in wild-type and SIRT2/MEFs analyzed by real-time PCR. (H) Average density of H3K9me3 in pericentromeric
heterochromatin in wild-type and SIRT2/ MEFs. (I) Quantitative analysis of 53BP1 focus formation at X-ray (IR)-induced DSBs in wild-type
and SIRT2/MEFs as shown in J throughout progression of the cell cycle (n > 20 for each time point) (J) Microscopic analyses of DNA damage
marked by accumulation of 53BP1. The S-phase cells were stained by EdU incorporation and counterstained with DAPI. Bar, 5 mm.
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SirT2 has a progressive effect on the conversion of
H4K20me1 to H4K20me2/3 (Fig. 5C) and that SirT2 does
not interact or colocalize with any of the Suv4-20h
enzymes (Supplemental Fig. 4A; data not shown) support
the idea that all of these events stem from the mitotic
deposition of H4K20me1 by PR-Set7. The major role of
SirT2 as a regulator of H4K20 methylation is also sup-
ported by strong functional data. One key observation is
thatMEFs defective in either SIRT2/ or both Suv4-20h1
and Suv4-20h2 (Suv4-20DN) exhibit almost identical cell
cycle distribution effects: Compared with wild-type
MEFs, they have more cells in G1, fewer cells in S phase,
and a slight increase in the number of cells progressing
through G2/M (Supplemental Fig. 4B) (Vaquero et al.
2006; Schotta et al. 2008). As expected, SIRT2/ cells
exhibit various defects in cell cycle progression and in
genome stability that have previously been described for
cases of total or partial loss of H4K20me1–H4K20me3.
First, SIRT2/ cells exhibit significantly higher levels of
rereplication than wild-type cells (Fig. 5D,E; Tardat et al.
2010), a phenomenon that occurs after S-phase comple-
tion, in which some cells already entering G2/M (labeled
by cyclin B1) restart the replication process (as measured
by EdU incorporation). Thus, not only does the SIRT2/
cell population contain a higher level of >4n cells positive
for EdU (Fig. 5D), but a significant number of these cells
are positive for cyclin B1 (Fig. 5E). Second, and in agreement
with the previously described accumulation of SIRT2/
MEF populations in G1/S (Vaquero et al. 2006), these cells
suffer from delayed S-phase entry but then undergo
accelerated progression through S phase, as has previ-
ously been shown for Suv4-20DN (Fig. 5F; Schotta et al.
2008; Tardat et al. 2010). Although these effects are not
well understood, one possible explanation is based on the
proposed role of H4K20me1 in licensing of replication
origins during replication (Tardat et al. 2010) as well as on
the role of H4K20me1/2 in DNA repair during replication
(Sanders et al. 2004; Tardat et al. 2007). Alterations of
these marks may initially delay entry into S phase, but
once cells have entered this phase, these alterations may
promote faster progression through S phase without any
supervision or repair. Third, given the critical role of
H4K20me3 in the heterochromatin structure and its
intimate relationship with H3K9me3 (Schotta et al.
2004), we reasoned that the decrease in the H4K20me3
levels observed in SIRT2/ cells should produce defects
in pericentromeric constitutive heterochromatin (PCH).
Thus, the PCH structure of these cells is defective, as
indicated by the derepression of the major heterochro-
matin g-satellite and the reduced density of H3K9me3 in
the heterochromatin foci (Fig. 5G,H). Finally, the obser-
vation that there is a decrease in the number of 53BP1
foci upon DNA damage during S phase, as has pre-
viously been reported for the loss of H4K20me1 and
H4K20me2 (Sanders et al. 2004; Schotta et al. 2008),
confirms that there is a defect in DNA repair during
S phase (Fig. 5I,J). Overall, these data support a major
role for SirT2 in cell cycle control—specifically in S-phase
progression—through the regulation of H4K20me1 depo-
sition during mitosis.
SirT2/ mice suffer from greater DNA damage
and genome instability
Overall, our data presented above suggest that the loss
of SirT2 is associated with greater genome instability.
Therefore, we next sought to determine whether adult
fibroblasts derived from these animals exhibit signifi-
cantly higher levels of DNA damage compared with cells
from their wild-type littermates. Comet assays clearly
showed that this was indeed the case: The SIRT2/ cells
contained high levels of double-strand breaks (DSBs) (Fig.
6A–C), which were further confirmed by measuring the
DSB marker gH2AX in IF and Western blot experiments
(Fig. 6D; Supplemental Fig. 5A,B). Interestingly, and con-
trary to what we had expected, we observed only a slightly
higher number of DSBs (as measured by gH2AX) in the
G1 phase (Fig. 6E; Supplemental Fig. 5C). Considering the
previously mentioned possibility that global H4K16Ac
deacetylation in G2/M might strongly affect the mitotic
compaction of chromatin and given the H4K16 hyper-
acetylation that we observed in SIRT2/ cells, we had ex-
pected to see major damage in G1. These results challenge
the view, based on the in vitro studies, that H4K16Ac
deacetylation may not be as important for in vivo chro-
matin compaction. Interestingly, the greatest DNA dam-
age in these cells was observed in S phase (Fig. 6E; Sup-
plemental Fig. 5C), a finding that supports the premise that
the H4K20me1 and H4K20me2 levels in these cells were
defective (Tardat et al. 2010). A detailed analysis showed
that the damage accumulates throughout S phase (Fig. 6F;
Supplemental Fig. 5D). In agreement with these observa-
tions, the SIRT2/mice exhibited markedly higher levels
of gH2AX in their tissues (Fig. 6G; Supplemental Fig. 5E)
and significantly higher rates of polyploidy in their cells
(Figs. 5D, 6H). The expression of active SirT2, but not of
the inactive SirT2 H150Y mutant, was able to rescue the
levels of g-H2AX, confirming a direct role of SirT2 activity
in these processes (Supplemental Fig. 5F,G). Considering
the results of these experiments, we reasoned that SIRT2/
mice should contain a significant number of chromo-
somal aberrations. To test this hypothesis, we performed
fluorescence in situ hybridization (FISH) experiments
with telomeric and centromeric probes in metaphase
chromosome spreads from SIRT2/ and wild-type cells
(Fig. 6I). The analysis of these spreads clearly indicated
a greater frequency of defects associated with alterations
in constitutive heterochromatin structure (summarized
in Fig. 6J), which supported our evidence for the drastic
alteration of H4K20me1, H4K20me2, and H4K20me3 in
these cells. Quantification of these aberrations demon-
strated that SIRT2/ animals clearly have higher levels
of genomic instability than their wild-type counterparts.
SirT2/ animals are more prone to develop tumors
in an induced skin tumorigenesis assay
The above-described data support the previously formu-
lated hypothesis that SirT2 is a tumor suppressor (Bosch-
Presegue and Vaquero 2011; Kim et al. 2011). Given that
SIRT2/ animals suffer from such a high degree of genomic
damage, they would be expected to be more prone than
SirT2 regulates H4K20 methylation by Pr-Set7
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wild-type animals to develop tumors. We tested this
hypothesis by evaluating our SIRT2/ mice in a DMBA/
TPA-induced skin tumorigenesis assay (Blanco et al. 2007).
For this assay, we treated a portion of the skin with the
mutagenic agent DMBA once and then treated the same
site with the proliferation-inducing agent TPA twice
weekly for 15 wk (Fig. 7A). During and after the treatment
period, we characterized the formation of papillomas and
determined whether any of the animals developed tumors.
Our analysis showed that starting at the eighth week of
treatment, the SIRT2/mice developed larger papillomas
at higher frequencies (Fig. 7B–D; Supplemental Fig. 6).
Strikingly, 35 wk after the end of the 15-wk treatment,
50% of the SIRT2/mice had died, whereas 100% of the
wild-type mice were still alive (Fig. 7E). The histopatho-
logical study of these animals confirmed thatmost of them
had developed malignant tumors, including different lo-
cally aggressive and metastatic forms of squamous cell
carcinoma and fibrosarcoma (Fig. 7F; Supplemental Fig. 6).
Therefore, our studies confirmed that the SirT2 loss is
associated with a greater risk of tumorigenesis, which
corroborates a role for SirT2 in cancer and pinpoints it as
a bona fide tumor suppressor (Bosch-Presegue and Vaquero
2011). Interestingly, and in contrast to a recent report on
another SIRT2 knockout mouse model (Kim et al. 2011),
these SIRT2/mice did not spontaneously develop tumors
within their first year. The difference may lie in the strains:
Whereas the earlier study used a mixed-lineage strain, the
knockout mice described here were C57-BL6, a strain well
known for its high resistance to tumor development.
Figure 6. SIRT2/ mice exhibit major DNA damage and genomic instability. (A) DNA damage in wild-type (WT) and SIRT2/
primary fibroblasts, as measured by neutral comet assay. (B,C) Quantification of experiments shown in A. The data shown are the
percentages of DNA present in the comet tail (B) or the tail moment quantification (C). (D) IF experiments on wild-type and SIRT2/
MEFs of BrdU incorporation. DAPI staining of cells is shown as a control for DNA. (E) Quantitative analysis of gH2AX levels of wild-
type and SIRT2/ MEFs throughout progression of the cell cycle (n > 20 for each time point). (F) Quantitative analysis as in E, but
focused on progression through S phase. (S-E) Early S phase; (S-M) middle S phase; (S-L) late S phase. (G) gH2AX levels in liver
cryosections derived from wild-type or SIRT2/ mice, detected by immunohistochemistry. (H) Quantification of polyploidy levels
from the FACS profiles shown in Figure 5D in wild-type and SIRT2/ fibroblasts. (I) IF of metaphase chromosome spreads from wild-
type and SIRT2/ primary fibroblasts stained with FISH chromosome paints for centromeres (CEN) and telomeres (TEL) and
counterstained with DAPI. The arrows indicate chromosomal aberrations relative to lost or duplicated centromeres and telomeres. (J)
Quantification of chromosomal aberrations observed in I.
Serrano et al.
648 GENES & DEVELOPMENT
 Cold Spring Harbor Laboratory Press on February 1, 2019 - Published by genesdev.cshlp.orgDownloaded from 
Overall, our results support a role for SirT2 as a key
maintainer of genome stability and as a tumor suppressor.
Discussion
Evidence accumulated during the last decade has chal-
lenged the classical view of mitosis as a cell cycle phase
focused exclusively on chromatid segregation and nuclear
division. Other critical events that occur during mitosis
apparently determine events in the subsequent cell
cycles. These processes include the establishment of the
epigenetic mark H4K20me1, a cornerstone of cell cycle
progression and genomic stability. Here, we characterized
an unexpected role for SirT2 in the deposition of this
mark during early mitosis and the establishment of a pre-
viously unknown functional relationship with PR-Set7.
Our findings include the first report of an acetylation/
deacetylation mechanism by which SirT2 modulates the
activity of PR-Set7.We also linked PR-Set7 andH4K20me1
to a SirT2-dependent mitotic checkpoint, suggesting an
active role of PR-Set7 in these processes—one that is far
more complex than previously anticipated. Furthermore,
Figure 7. SIRT2/mice are more prone to tumorigenesis. (A) Schematic representation of the DMBA/TPA-induced skin tumorigenesis
assay. (B) Average number of papillomas per mouse at the indicated number of weeks after starting the DMBA/TPA treatment. The
treatment was interrupted at week 15. (C) Papilloma size in wild-type (WT) versus SIRT2/ mice at week 25 after starting the
treatment. (D) Representative wild-type and SIRT2/ animals in week 25. (E) Survival curve of DMBA/TPA-treated wild-type and
SIRT2/ mice. (F) Representative examples of the neoplasias and metastases indicated in E developed by SIRT2/ mice. (Top left
image) Lung metastasis of a poorly differentiated skin squamous cell carcinoma. (Top right) Poorly differentiated skin squamous cell
carcinoma (SCC pd) with pleomorphism and numerous mitotic cells, clearly growing invasively into the dermis, subcutaneous tissue,
and subcutaneous muscle. (Bottom left) In situ skin squamous cell carcinoma (SCC in situ) with focal basal membrane disruption.
(Bottom right) Cutaneous fibrosarcoma with pleomorphic spindle cells that invade skeletal muscle. (G) Proposed model of the
regulation of H4K20me1 deposition by SirT2 based in our results. (1) PR-Set7 recruits SirT2 to specific chromatin regions. SirT2 then
deacetylates both PRSet7 (2) and H4K16Ac (3) from neighboring nucleosomes. PR-Set7 deacetylation in K90 induces its mobilization.
(4) Then, SirT2-bound PR-Set7 monomethylates H4K20 in the neighbor nucleosome. This is followed by translocation to the following
nucleosome, where deacetylation of H4K16Ac (5) and H4K20me1 (6) take place again. Overall, we propose that SirT2 regulates the
activation and spreading of PR-Set7 in G2/M.
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we presented the first report of a crucial role for Sirtuins
in cell cycle control via the modulation of epigenetic
information; our findings suggest that each cell cycle
undergoes constant and dynamic modulation to protect
genome integrity in the subsequent cell cycle. These
findings offer new insight into the way that basic cellular
mechanisms, such as cell cycle progression, are modu-
lated through constant cross-talk between a cell’s envi-
ronment and epigenetic regulatory memory.
A functional relationship involving SIRT2, H4K16Ac,
and PR-Set7
Among the most interesting aspects of this work is the
elucidation of a relationship between SirT2 and PR-Set7.
Interestingly, both enzymes are phosphorylated around
the G2/M transition by CDK1/cyclin B and dephosphory-
lated around early anaphase by Cdc14a,b phosphatases
(North and Verdin 2007b; Wu et al. 2010). As previously
described for SirT1 and Suv39h1, SirT2 promotes PR-Set7
activity through a combination of mechanisms, including
the deacetylation of H4K16Ac and binding to PR-Set7,
which appears to increase the specific activity of the en-
zyme. However, SirT2 appears to have an even more
complex role, as it apparently alters the levels of PR-Set7
on chromatin. In this sense, the deacetylation of PR-Set7
at K90 by SirT2 appears to be important for allowing the
proper dynamic binding of the methyltransferase to the
chromatin, which most likely also determines the focal
architecture. The PR-Set7 point mutant K90Q, which
mimics K90Ac, forms more foci that contain a lower
density of protein compared with the wild-type or K90R
proteins but binds to SirT2 with less affinity than K90R.
These observations suggest that K90 acetylation may
be required in the early stages of PR-Set7 arrival to the
chromatin, whereas the SirT2-mediated deacetylation of
K90 may help mobilize PR-Set7, allowing the spread of
H4K20me1.
Based on our findings, we therefore hypothesize that
during mitosis, SirT2 regulates H4K20me1 deposition via
PR-Set7 and propose a model for H4K20me1 spreading.
PR-Set7 initially arrives at the chromatin during late G2,
likely in an acetylated state at K90, and recruits SirT2
during G2/M. In turn, SirT2 promotes the enzymatic
activity of PR-Set7 through the aforementioned mecha-
nism (Fig. 7G) and deacetylates K90. The effects ofH4K16Ac
deacetylation by SirT2 on neighboring nucleosomes then
enables the spread of PR-Set7 binding on chromatin and
the subsequent methylation of these nucleosomes. Fu-
ture studies should determine the validity of this model.
Of particular importance is the identification of the re-
gions in H4K20 that are monomethylated by PR-Set7 and
those acetylated at H4K16 in wild-type and SIRT2/
cells during early mitosis.
H4K20 methylation defects and genomic instability
Although the loss of SirT2 also correlates with a global
decrease in H4K20me2/3 and the cell cycle distribution of
Suv4-20DNMEFs is strikingly similar to that of SIRT2/
MEFs (Supplemental Fig. 4A; Vaquero et al. 2006; Schotta
et al. 2008), our findings support the idea that all of these
effects are produced by a decrease in PR-Set7 function.
Not only are the partial losses of me1–me3 progressive
(see the table in Fig. 5C), but the loss of SirT2 does not
associate with any accumulation of H4K20me1, in con-
trast to what has been shown for Suv4-20DN (Schotta
et al. 2008). Instead, this profile fits perfectly with pre-
vious reports that PR-Set7 activity leads to the depletion
of H4K20me1 and reduced levels of H4K20me2/3 (Oda
et al. 2009).
Interestingly, other investigators have previously
claimed that SirT2 is involved in the modulation of
APCCdh1 activity through the deacetylation of Cdh1 (Kim
et al. 2011), an event that might be involved in genomic
stability. However, the observations in our mouse model
suggest that this activity may not be that functionally
relevant and that it cannot be the main cause of genomic
instability. Thus, considering that APCcdh1 has been shown
to regulate PR-Set7 levels during late mitosis, we would
expect that the total levels of PR-Set7 would be altered in
SIRT2/ cells. However, we did not observe any changes
in our cells (Supplemental Fig. 2D). Moreover, if the in-
creased DNA damage observed in the SirT2-deficient
cells was the result of mitotic defects in general, then
we would not expect the bulk of the damage to accumu-
late in S phase, which is what we observed.
Consistent with a key role of SirT2 in H4K20 methyla-
tion in vivo, SIRT2/mouse cells exhibit myriad specific
phenotypes that have been assigned to defects in the
mono-, di-, or trimethylation of H4K20. Therefore, our
findings strongly suggest that the main driver of the
genomic instability detected in these mice is a global
defect in H4K20 methylation—a link that has been well
established by multiple reports (Jorgensen et al. 2007;
Tardat et al. 2007; Houston et al. 2008; Schotta et al. 2008;
Oda et al. 2009). However, although PR-Set7 knockout
causes death in the embryonic stage in mice (Oda et al.
2009) and in the third-instar larval stage in Drosophila
(Karachentsev et al. 2005), we never observed develop-
mental defects in the SIRT2/ mice, possibly because
SirT2 does not affect PR-Set7 activity during develop-
ment or because of the existence of some redundant
activity during this process. Alternatively, the fact that
SirT2 loss leads to drastically lower levels of H4K20me1
but does not eliminate it completely suggests that the
reduced levels of H4K20me1 are sufficient to progress
through development. Therefore, additional experiments
are required to clarify this process.
SirT2, PR-Set7, and a mitotic checkpoint
Our studies have shown that SirT2 and PR-Set7 may
function together in a mitotic checkpoint mechanism
and suggest a previously unknown role for H4K20me1 in
mitosis. In fact, the involvement of SirT2 in a G2/M
mitotic checkpoint has previously been proposed (Inoue
et al. 2007) as a response to chronic stress produced by
microtubule inhibitors. Our evidence suggests that under
stress, SirT2 strongly binds to PR-Set7 and that this bind-
ing is associated with the enrichment of both proteins in
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insoluble chromatin, which correlates with the blocking
of mitosis and an accumulation of H4K20me1. This sce-
nario is supported by the observation that under stress,
SIRT2/ cells do not experience either blocked G2/M or an
increase in H4K20 methylation. A role for H4K16Ac in
mitotic entry and control is corroborated by the finding that
the depletion of MOF in mouse cells leads to an accumu-
lation of cells in G2/M (Smith et al. 2005; Taipale et al.
2005). However, many questions remain to be addressed in
future works, such as: What is the exact role of PR-Set7? Is
the H4K20me1 peak part of the mitotic checkpoint or
simply a consequence of PR-Set7 activation under stress?
The interplay between H4K16Ac and H4K20me1
in mitosis
Another interesting point is the extent of the antagonism
between H4K16Ac and H4K20me1. Although the inhib-
itory effect of H4K16Ac on PR-Set7 was originally pro-
posed in the context of peptides as substrates and of a PR-
Set7 mutant capable of targeting nonnucleosomal sub-
strates (Nishioka et al. 2002b), here we demonstrated that
this inhibition is also valid in the context of the wild-type
enzyme and nucleosomes (Fig. 3A,B). This interplay is
supported by the finding that H4K16Ac inhibits not only
the specific activity of PR-Set7, but also the binding of
specific factors to these marks, such as 53BP1, a binding
factor specific for H4K20me1/2 (Supplemental Fig. 7).
Although researchers originally proposed that the pres-
ence of both modifications in the same H4 N-terminal
tail alone could represent a steric problem, subsequent
studies have demonstrated that this is not the case and
that H4K16Ac actually coexists with all three levels of
H4K20 methylation (Fraga et al. 2005; Pesavento et al.
2008). This coexistence suggests that the antagonismmay
be unidirectional and that H4K20 methylation might not
efficiently inhibit H4K16 acetylation. Given the general
role of H4K16Ac in regulating chromatin structure and its
association with active transcription, H4K20me1 genome-
wide distribution might be expected to be restricted to
inactive regions. However, the analysis of nine different
human cell lines from different tissues and/or differentia-
tion stages by chromatin immunoprecipitation (ChIP) se-
quencing has revealed that H4K20me1 is actually present
in highly expressed genes in all cell types (Beck et al.
2012)—a finding that argues against a general global inter-
play between the two modifications. In contrast, our ob-
servations do support the existence of an antagonistic
effect between these two modifications that is restricted
to early mitosis, as the loss of SirT2 correlates with an
inversion in the levels of H4K16Ac and H4K20me1 (Fig.
2B,C). Determining the precise conditions and limits for
this antagonism should be an exciting and fruitful research
focus of future epigenetic studies.
Materials and methods
IF, immunohistochemistry, and comet assays
The IF and immunohistochemistry experiments were performed
as described elsewhere (Vaquero et al. 2006). The images were
acquired using a Zeiss LSM510 Meta confocal laser-scanning
microscope. Three-dimensional reconstructions and image anal-
ysis were conducted using Imaris software (Bitplane, A.G.). FISH
on metaphase chromosome spreads was performed according
to the StarFISH Protocol N Pan Telomeric and Centromeric
Chromosome Paints (Cambio 1696). To detect DSBs, the neutral
comet assay was performed as described previously (Olive and
Banath 2006). The images were acquired using a Leica AF-5000
confocal microscope and analyzed and quantified using the
Comet Score program.
Chromatin fractionation
HeLa cells were transfected with SirT2-HA, Flag-PR-Set7, or
both and then synchronized using a double-thymidine block as
described in the Supplemental Material. The cells were then
harvested at different times after G1/S release. The cell cycle
stage was determined using FACS analysis. For the chromatin
fractionation, after the Dignam protocol extraction, the chroma-
tin pellet was washed once with BC-500 and then dissolved in
Laemmli buffer by sonication in a water bath.
Tumor induction experiments and histopathological analysis
Fourteen age-matched (8- to 12-wk-old) mice of each genotype—
SIRT2/ and wild type, respectively—were treated with DMBA
and TPA according to Blanco et al. (2007). The number and size of
papillomas per mouse were recorded weekly. Skin samples and
other mouse tissues were recovered after sacrifice and embedded
in paraffin according to standard protocols. For histopathological
study, hematoxylin–eosin stain was used.
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